omersukrugoksu / iStockphoto.com
11 September 2018Big PharmaGabriel Cuonzo and Luca Pellicciari
Boehringer v Teva: Italian court clarifies boundaries of Bolar privilege
With a ground-breaking decision issued on July 24, 2018, the Milan Court found Teva and its affiliate company Sicor liable for patent infringement in a case concerning Boehringer Ingelheim’s exclusive rights on the active pharmaceutical ingredient (API) tiotropium bromide, used in Boehringer Ingelheim’s product Spiriva for the management of chronic obstructive pulmonary disease.
